Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1997-10-17
1999-02-02
Patterson, Jr., Charles L.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
435193, 4353201, 4352523, 536 232, C12N 922
Patent
active
058663983
ABSTRACT:
The methylase selection method was used to clone the BslI methylase gene (bslIM) from Bacillus species. A partially active BslI methylase lacking the 17 amino acid residues at the N-terminus was cloned in E. coli using expression vector pRRS. Inverse PCR was used to clone the missing portion of the BslI methylase. After cloning the complete BslI methylase gene and its upstream DNA sequences, a RadC homolog was found upstream of the BslI methylase. Because methylase gene and restriction endonuclease gene are located in proximity to each other in a particular restriction-modification system, efforts were made to clone the downstream DNA by inverse PCR. After two round of inverse PCR reactions two open reading frames (ORF) were found downstream of the BslI methylase gene. Expression of the first ORF (ORF1) in a T7 expression vector did not yield any active BslI endonuclease. Expression of the second ORF (ORF2) in E. coli and assay of the crude cell extract indicated that this gene product has DNA nicking activity. The gene product of ORF2 alone does not constitute BslI endonuclease activity. Expression of ORF1 and ORF2 in the same E. coli cell produces BslI endonuclease activity. BslI endonuclease activity can be reconstituted in vitro by mixing gene product of ORF1 and ORF2 together.
REFERENCES:
patent: 5200333 (1993-04-01), Wilson
patent: 5498535 (1996-03-01), Fomerkov et al.
Roberts and Macelis, Nucl. Acids Res. 24:223-235 (1996).
Kong, et al., J. Biol. Chem., 268:1965-1975 (1993).
Kosykh, et al., Mol. Gen. Genet., 178:717-719 (1980).
Mann, et al., Gene, 3:97-112 (1978).
Walder, et al., Proc. Natl. Acad. Sci. USA 78:1503-1507 (1981).
Bougueleret, et al., Nucl. Acids. Res., 12:3659-3676 (1984).
Gingeras and Brooks, Proc. Natl. Acad. Sci. USA, 80:402-406 (1983).
Theriault and Roy, Gene, 19:355-359 (1982).
Blumenthal, et al., J. Bacteriol., 164:501-509 (1985).
Kiss, et al., Nucl. Acids Res., 13:6403-6421 (1985).
Szomolanyi, et al., Gene, 10:219-225 (1980).
Janulatis, et al., Gene, 20:197-204 (1982).
Kiss and Baldaud, Gene, 21:111-119 (1983).
Walder, et al., J. Biol. Chem., 258:1235-1241 (1983).
Fomenkov, et al., Nucl. Acids Res., 22:2399-2403 (1994).
Jack, et al., Nucl. Acids Res., 19:1825-1829 (1991).
Stankevicius, et al., 1. p.11 "Unique Structure of the Typell Restriction-Modification System Bpu101" The 4th New England Biolabs Workshop on Biological DNA Modification Innsbruck, IGLS, Sep. 2, 1997 -Sep. 7, 1997, p. 91.
Xiao Jian-ping
Xu Shuang-yong
New England Biolabs Inc.
Patterson Jr. Charles L.
Williams Gregory D.
LandOfFree
Method for cloning and producing the BS1I restriction endonuclea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for cloning and producing the BS1I restriction endonuclea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for cloning and producing the BS1I restriction endonuclea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1116542